Oncolytics Biotech Inc. Stock Nasdaq
Equities
CA6823101077
Biotechnology & Medical Research
Sales 2024 * | 857K 623K | Sales 2025 * | 6.68M 4.85M | Capitalization | 109M 78.94M |
---|---|---|---|---|---|
Net income 2024 * | -36M -26.17M | Net income 2025 * | -40M -29.08M | EV / Sales 2024 * | 127 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 16.3 x |
P/E ratio 2024 * |
-3.22
x | P/E ratio 2025 * |
-3.25
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.84% |
Latest transcript on Oncolytics Biotech Inc.
Managers | Title | Age | Since |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-10 |
Kirk Look
DFI | Director of Finance/CFO | - | 03-03-31 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 22-09-06 |
Patricia Andrews
BRD | Director/Board Member | 66 | Jan. 08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 15-06-07 |
1st Jan change | Capi. | |
---|---|---|
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |